Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Glucosylceramidase antibody (Center)

This Rabbit Polyclonal antibody specifically detects Glucosylceramidase in WB, FACS, IHC and ELISA. It exhibits reactivity toward Human.
Catalog No. ABIN2272615

Quick Overview for Glucosylceramidase antibody (Center) (ABIN2272615)

Target

Glucosylceramidase (GLCM)

Reactivity

  • 6
  • 3
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Human

Host

  • 5
  • 1
Rabbit

Clonality

  • 5
  • 1
Polyclonal

Conjugate

  • 4
  • 1
  • 1
This Glucosylceramidase antibody is un-conjugated

Application

  • 6
  • 2
  • 2
  • 2
  • 1
Western Blotting (WB), Flow Cytometry (FACS), Immunohistochemistry (IHC), ELISA
  • Binding Specificity

    • 3
    • 3
    • 1
    AA 337-365, Center

    Cross-Reactivity

    Human, Mouse (Murine)

    Cross-Reactivity (Details)

    Calculated cross reactivity: Hu Mo

    Characteristics

    GC (Glucosylceramidase, GLUC, Acid beta-Glucosidase, GBA, Alglucerase, beta-Glucocerebrosidase, D-glucosyl-N-acylsphingosine Glucohydrolase, Imiglucerase)

    Purification

    Purified by Protein A affinity chromatography.

    Immunogen

    KLH-conjugated synthetic peptide mapping to a fragment of residues within amino acids 337-365 in the central region of human GC, UniProt Accession #P04062. Species Sequence Homology: bovine and porcine

    Isotype

    IgG
  • Application Notes

    Optimal working conditions should be determined by the investigator.

    Restrictions

    For Research Use only
  • Format

    Liquid

    Buffer

    Supplied as a liquid in PBS, 0.09 % sodium azide.

    Preservative

    Sodium azide

    Precaution of Use

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    -20 °C

    Storage Comment

    -20°C
  • Target

    Glucosylceramidase (GLCM)

    Alternative Name

    Glucosylceramidase

    NCBI Accession

    NP_000148

    UniProt

    P04062
You are here:
Chat with us!